Fact CheckerSign in

NCT04578301Recruiting

Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver Disease

Source: ClinicalTrials.gov · Last updated 18 May 2022 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Prospective, observational study to define precipitants and predictors of development of Acute-on-Chronic Liver Failure (ACLF) after surgical interventions, allowing to develop a risk stratification for elective procedures in cirrhotic patients. As well as identifying molecular mechanisms of post-interventional ACLF and thus preparing the ground for development of new therapeutic approaches.

Status (registry)
Recruiting
Study type
Observational
Enrollment
200 (estimated)
First submitted
22 Sept 2020
Start date
22 Sept 2020
Primary completion date
31 Dec 2025
Lead sponsor
University Hospital, Bonn
NCT number
NCT04578301

What you commit to

  • Study type: Observational
  • Planned participants: 200
  • From 22 Sept 2020 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous liver or other transplantation

Other illness

  • Patients undergoing surgery as form of palliative cancer therapy
  • Presence or history of severe extra-hepatic diseases
  • HIV-positive patients
  • Patients with acute or subacute liver failure without underlying cirrhosis

Other

  • Pregnant or lactating females
  • Patients who decline to participate
  • Physician´s denial (e.g. the investigator considers that the patient will not follow the protocol scheduled)

Who the study is looking for

  • Male or female adult (≥18 years) patient
  • With or without liver cirrhosis (diagnosed either histologically or by a combination of clinical, laboratory and radiological signs)
  • Or Non-cirrhotic portal hypertension
  • Non-pregnant, non-lactating females
  • Ability to understand the patient information and to personally sign and date the informed consent to participate in the study
  • The patient is co-operative and available for the entire study
  • Provided written informed consent
  • Indication for surgical intervention

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital Bonn
Coordinator of this site? Confirm its status
BonnGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.